4 ms·
Pivoting doesn't make a lot of sense in this space. However it is entirely possible to be agile and (relatively) fast in this space - not by breaking rules but
by ska 11y ago
Pivoting doesn't make a lot of sense in this space.
However it is entirely possible to be agile and (relatively) fast in this space - not by breaking rules but by designing the process to be light where it can, detailed where it must. And then paying attention to how it is working and improving it constantly. You can probably cut time to market in half relative to industry averages this way, which is nothing to sneeze at.
- hga 11y agoPivoting after losing your reputation for quality and playing straight with the FDA makes no sense whatsoever to me. In fact, the FDA is known for getting very vindictive after that sort of thing happens. I count this as different than the 23AndMe situation where they're arguing with the FDA over how the results can interpreted and passed on to the consumer, that's a difference in opinion that doesn't rest on the quality of the testing science.
- ska 11y agothat's a difference in opinion Indications for use aren't a matter of opinion. 23AndMe clearly screwed up there, but I agree it was a different nature of screw up.